Coordination between proteasome impairment and caspase activation leading to TAU pathology: neuroprotection by cAMP.
about
The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord InjuryTau clearance mechanisms and their possible role in the pathogenesis of Alzheimer diseaseTau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling.Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.Extended ubiquitin species are protein-based DUB inhibitors.Regulating the ubiquitin/proteasome pathway via cAMP-signaling: neuroprotective potentialThe interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration.The Proteasome and Oxidative Stress in Alzheimer's Disease.Neurotoxic mechanisms by which the USP14 inhibitor IU1 depletes ubiquitinated proteins and Tau in rat cerebral cortical neurons: Relevance to Alzheimer's disease.PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2.Prostaglandin J2 promotes O-GlcNAcylation raising APP processing by α- and β-secretases: relevance to Alzheimer's disease.Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology.
P2860
Q26767879-1C83E108-9EEE-4E80-99C1-45522F289B92Q26995276-E60E9A7F-F74D-40A7-ABFF-A03302EA41DBQ34506149-F63E5D81-2BF2-4921-A4D6-BD034246B808Q34508284-50A8D9CB-1ABB-4A83-B756-AEFCABF2D128Q34933261-A1389536-AE77-44A0-A4FD-FD7DCA8FD9D0Q35152946-366FD0C6-71B2-43EE-82FA-6C8D39FC405BQ35739138-62E1B7C4-7CC5-4077-8357-638914AD1F6FQ37136291-675E2FE8-6B7F-4635-9432-C58594550577Q38520167-2684725D-4C13-4595-B94A-F940681BF64DQ38843876-DFC8ABC3-F03D-482E-93C3-C7A8B89436EAQ41323064-48DB2686-E721-4AD6-8514-517F371EA263Q41769727-082F1D40-6120-409B-A7C1-F6AB413B27DCQ47391212-762CB9DE-3F42-4D35-B8D1-EF5165A9DF82Q55003043-AA4C69A4-94EE-4009-98B8-5AF5C048066A
P2860
Coordination between proteasome impairment and caspase activation leading to TAU pathology: neuroprotection by cAMP.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Coordination between proteasom ...... logy: neuroprotection by cAMP.
@ast
Coordination between proteasom ...... logy: neuroprotection by cAMP.
@en
type
label
Coordination between proteasom ...... logy: neuroprotection by cAMP.
@ast
Coordination between proteasom ...... logy: neuroprotection by cAMP.
@en
prefLabel
Coordination between proteasom ...... logy: neuroprotection by cAMP.
@ast
Coordination between proteasom ...... logy: neuroprotection by cAMP.
@en
P2093
P2860
P356
P1476
Coordination between proteasom ...... logy: neuroprotection by cAMP.
@en
P2093
M E Figueiredo-Pereira
M J Metcalfe
P2860
P356
10.1038/CDDIS.2012.70
P577
2012-06-21T00:00:00Z